Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hubert de Boysson

Showing results (11-20 of 125) with videos related to

Pageof 13
Sort By:
Medecine Sciences : M/S|August 28, 2012
[Use of regulatory T cells in cellular therapies in autoimmune diseases]Guilaine Boursier, Aurélie Siri, Hubert de Boysson
Medecine Sciences : M/S|July 19, 2012
[Regulatory T lymphocytes CD4(+): current issues]Aurélie Siri, Hubert de Boysson, Guilaine Boursier
Presse Medicale (Paris, France : 1983)|February 14, 2012
[Cerebral vasculitides]Hubert de Boysson, Anthony Faivre, Christian Pagnoux
The Lancet. Rheumatology|August 25, 2020
Anakinra for patients with COVID-19Nicolas Martin-Silva, Hubert de Boysson, Achille Aouba
The Journal of Rheumatology|December 3, 2013
Rituximab for primary angiitis of the central nervous system: report of 2 patients from the French COVAC cohort and review of the literatureHubert De Boysson, Caroline Arquizan, Loic Guillevin, et al.
Clinical Nuclear Medicine|October 15, 2021
JAK Inhibitor Effectiveness in Giant-Cell Arteritis With Large-Vessel Involvement Assessed by 18F-FDG PET-CTKevin Prigent, Achille Aouba, Nicolas Aide, et al.
Rheumatology (Oxford, England)|December 7, 2023
18FDG PET/CT: an aid for the early diagnosis of paucisymptomatic polyarteritis nodosaRémi Philip, Catherine Nganoa, Hubert De Boysson, et al.
Modern Rheumatology|December 7, 2016
Treatment of giant-cell arteritis, a literature reviewBénédicte Watelet, Maxime Samson, Hubert de Boysson, et al.
Journal of Musculoskeletal & Neuronal Interactions|December 3, 2019
Chronic intestinal pseudo-obstruction with dilated biliary tract as a spectrum of stiff person syndrome in a nondiabetic patientAlexandre Nguyen, Hubert de Boysson, Fohlen Audrey, et al.
Clinical Rheumatology|October 31, 2012
Tocilizumab in the treatment of the adult-onset Still's disease: current clinical evidenceHubert de Boysson, Jérome Février, Amélie Nicolle, et al.
Pageof 13

Showing results (11-20 of 125) with videos related to

Sort By:
Pageof 13
Medecine Sciences : M/S|August 28, 2012
[Use of regulatory T cells in cellular therapies in autoimmune diseases]Guilaine Boursier, Aurélie Siri, Hubert de Boysson
Medecine Sciences : M/S|July 19, 2012
[Regulatory T lymphocytes CD4(+): current issues]Aurélie Siri, Hubert de Boysson, Guilaine Boursier
Presse Medicale (Paris, France : 1983)|February 14, 2012
[Cerebral vasculitides]Hubert de Boysson, Anthony Faivre, Christian Pagnoux
The Lancet. Rheumatology|August 25, 2020
Anakinra for patients with COVID-19Nicolas Martin-Silva, Hubert de Boysson, Achille Aouba
The Journal of Rheumatology|December 3, 2013
Rituximab for primary angiitis of the central nervous system: report of 2 patients from the French COVAC cohort and review of the literatureHubert De Boysson, Caroline Arquizan, Loic Guillevin, et al.
Clinical Nuclear Medicine|October 15, 2021
JAK Inhibitor Effectiveness in Giant-Cell Arteritis With Large-Vessel Involvement Assessed by 18F-FDG PET-CTKevin Prigent, Achille Aouba, Nicolas Aide, et al.
Rheumatology (Oxford, England)|December 7, 2023
18FDG PET/CT: an aid for the early diagnosis of paucisymptomatic polyarteritis nodosaRémi Philip, Catherine Nganoa, Hubert De Boysson, et al.
Modern Rheumatology|December 7, 2016
Treatment of giant-cell arteritis, a literature reviewBénédicte Watelet, Maxime Samson, Hubert de Boysson, et al.
Journal of Musculoskeletal & Neuronal Interactions|December 3, 2019
Chronic intestinal pseudo-obstruction with dilated biliary tract as a spectrum of stiff person syndrome in a nondiabetic patientAlexandre Nguyen, Hubert de Boysson, Fohlen Audrey, et al.
Clinical Rheumatology|October 31, 2012
Tocilizumab in the treatment of the adult-onset Still's disease: current clinical evidenceHubert de Boysson, Jérome Février, Amélie Nicolle, et al.
Pageof 13